In a new study from the University of Sao Paulo, researchers found the blood thinner dabigatran produced similar results to warfarin for the prevention of cognitive decline in older adults with heart rhythm disorders.
Atrial fibrillation is the most common cardiac arrhythmia in older adults, and it is associated with an increased risk of stroke, cognitive impairment and dementia.
Stroke can occur when a blood clot blocks blood flow to the brain, and oral anticoagulants, or medications that prevent the formation of blood clots such as dabigatran and warfarin, are typically prescribed to prevent stroke.
Dabigatran has been found to be comparable to warfarin for the prevention of stroke and also has a lower risk of major bleeding complications.
In the study, the team examined the effects of dabigatran and warfarin on cognitive and functional impairment, bleeding occurrence and cerebrovascular complications in older patients with atrial fibrillation.
This study included 200 adults over age 70 with confirmed atrial fibrillation, and about 62% of the study participants were male.
Participants were randomly assigned to take dabigatran (110 or 150 mg twice daily) or warfarin (once daily, dose controlled based on how long it takes the blood to clot) for two years
Participants completed 90-minute cognitive and functional evaluations at the one-year and two-year follow-up visits.
The researchers found that after two years: no participant was diagnosed with dementia during the trial.
Among the entire study population, there was less than a half point difference (statistically not significant) between study participants taking warfarin and those taking dabigatran on scales measuring memory, executive functions, language and attention from baseline.
These findings highlight the importance of adequate anticoagulation treatment to decrease cognitive decline in older atrial fibrillation patients.
In addition, the researchers concluded that among older patients with atrial fibrillation who were adequately treated with warfarin or dabigatran, there was no difference in cognitive outcomes after two years of treatment.
If you care about brain health, please read studies about inflammation that may actually slow down cognitive decline in older people, and findings that low vitamin D may speed up cognitive decline.
For more information about brain health, please see recent studies about common exercises that could protect against cognitive decline, and results showing that this MIND diet may protect your cognitive function, prevent dementia.
The study was presented at the American Heart Association’s Scientific Sessions 2021. One author of the study is Bruno Caramelli, M.D.
Copyright © 2021 Knowridge Science Report. All rights reserved.
